Atezolizumab in combination with platinum-based chemotherapy for untreated locally advanced or metastatic urothelial cancer [ID1206]
Discontinued
Reference number: GID-TA10202
The Department for Health and Social Care has asked NICE to conduct an appraisal of atezolizumab in combination with platinum-based chemotherapy for the first-line treatment of adult patients with locally advanced or metastatic urothelial bladder cancer.
Please note that following on from advice received from the company the timelines for this appraisal have been revised and we now anticipate that the appraisal will begin during late August 2020 when we will write to you about how you can get involved.